0001437749-17-015114 Sample Contracts
LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between windtree therapeutics, inc. and Lee’s pharmaceutical (hk) LTD.License, Development and Commercialization Agreement • August 21st, 2017 • Windtree Therapeutics Inc /De/ • Biological products, (no disgnostic substances) • England and Wales
This License, Development and Commercialization Agreement (this “Agreement”) is entered into as of June 12, 2017 (the “Effective Date”), by and between Windtree Therapeutics, Inc., a Delaware corporation with its principal offices at 2600 Kelly Rd., Suite 100, Warrington, PA 18976 (“Licensor”), and Lee’s Pharmaceutical (HK) Ltd., a Hong Kong company organized and existing under the laws of Hong Kong with its principal offices at Unit 110-111, Bio-Informatics Centre, No. 2 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong (“Licensee”). Licensor and Licensee are sometimes referred to in this Agreement individually as a “Party” and together as the “Parties.”
